Loading...

Compass Therapeutics, Inc.

CMPX•NASDAQ
Healthcare
Biotechnology
$1.79
$-3.24(-64.38%)
U.S. Market opens in 3h 1m

Compass Therapeutics, Inc. (CMPX) Stock Overview

Explore Compass Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap246.8M
P/E Ratio-4.89
EPS (TTM)$-0.42
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$4.38
3 Months$5.65
1 Year Target$7.07

CMPX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Compass Therapeutics, Inc. (CMPX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 19.29, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $7.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.89 and a market capitalization of 246.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-64.38%
5-Day Change
-66.60%
1-Month Change
-65.64%
3-Month Change
-72.07%
6-Month Change
-56.45%
Year-to-Date (YTD) Change
-66.67%
1-Year Change
-5.79%
3-Year Change
-36.30%
5-Year Change
-78.94%
All-Time (Max) Change
-78.94%

Contact Information

https://www.compasstherapeutics.com
617 500 8099
80 Guest Street, Boston, MA, 02135

Company Facts

35 Employees
IPO DateApr 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions